P101 Regulatory T cells exhibit reduced phenotypic stability upon pro-inflammatory challenge in autoimmune hepatitis

• Published in: Gut Vol. 60; no. Suppl 2; p. A47
• Main Authors: Grant, C R, Holder, B, Ma, Y, Mieli-Vergani, G, Vergani, D, Longhi, M S
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group Ltd and British Society of Gastroenterology 01.09.2011; BMJ Publishing Group LTD
• Subjects: Adenosine; Age; ATP; CD25 antigen; CD28 antigen; CD3 antigen; CD4 antigen; CD73 antigen; Digestive tract; Ectonucleotidase; Flow cytometry; Fluorescence; Foxp3 protein; Hepatitis; Hydrolysis; Immune response (cell-mediated); Immunoregulation; Inflammation; Interleukin 1; Interleukin 10; Interleukin 17; Interleukin 6; Lymphocytes T; Monoclonal antibodies; Patients; Phenotypes; γ-Interferon
• ISSN: 0017-5749; 1468-3288
• DOI: 10.1136/gutjnl-2011-300857a.101

IntroductionIn autoimmune hepatitis (AIH) CD4+CD25high regulatory T-cells (Tregs) are numerically defective and fail to suppress T-cell-mediated immune responses. Expression by Tregs of the ectoenzyme CD39 contributes to their ability to suppress by initiating an ATP hydrolysis cascade which leads to the production of adenosine, a molecule with inhibitory properties. Recently expression of CD39 has been associated with T-reg phenotypic stability under inflammatory conditions.AimTo investigate the frequency and phenotypic stability of CD39+ Tregs in AIH.Method24 AIH patients (23 ANA/SMA+, 1 LKM-1+; 12 females, median age: 15 years) and 24 healthy subjects (HS; 16 females, median age: 35 years) were studied. The phenotype of circulating Tregs was assessed by flow cytometry using monoclonal antibodies to CD4, CD25, CD127, CD39 and CD73, an ectonucleotidase that in mice is expressed by Tregs and works in tandem with CD39. The frequency of IFNγ, IL10 and IL17-producing cells within Tregs was determined by intracellular staining. Analysis was performed at baseline and after exposure to anti-CD3/CD28 T-cell expander or to the pro-inflammatory cytokines IL1β and IL6 (IL1β+IL6).ResultsAt baseline, CD39+Tregs were less numerous in AIH (8.78±0.77) than HS (11.93±1.04, P=0.019) and displayed a trend towards higher CD127 expression (7.41±3.25 vs 2.75±1.33, p=0.13) and reduced FOXP3 mean fluorescence intensity (1230±260 vs 997±232, p=0.09). CD73 expression on CD39+Tregs did not differ between the two groups. Exposure to T-cell expander increased the frequency of IFNγ+CD39+Tregs in AIH (from 7.37±2.15 to 24.3±13.37, p=0.043) but not in HS (12.4±2.9 to 6.6±2.4, p=NS). Although the frequency of IFNγ+CD39+Tregs augmented after treatment with IL1β+IL6 in both AIH (from 7.37±2.15 to 72.9±9.42, p<0.001) and HS (12.39±2.94 to 56.51±16.12, p<0.001), the increase was higher in the former than in the latter (10-fold vs fivefold). IL1β+IL6 increased the frequency of CD127+CD39+Tregs in AIH (from 4.95±2.23 to 19.6±11.43, p=0.05) but not in HS (2.7±1.3 to 1.3±0.8 p=NS). No change in the frequency of IL10+ and IL17+CD39+Tregs was noted upon T-cell expander or IL1β+IL6 stimulation in AIH and HS.ConclusionCompared to HS, Tregs from AIH patients display lower CD39 expression and are more prone to become activated upon exposure to pro-inflammatory stimuli, a finding which indicates reduced phenotype stability. A decrease in CD39 expression and in phenotypic stability may contribute to impaired Treg suppressive function in AIH.